Immunotherapy in Breast Cancer: When, How, and What Challenges?

Breast Cancer (BC) is the second most frequent cause of cancer death among women worldwide and, although there have been significant advances in BC therapies, a significant percentage of patients develop metastasis and disease recurrence. Since BC was demonstrated to be an immunogenic tumor, immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriques, Beatriz, Mendes, Fernando, Martins, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616011/
https://www.ncbi.nlm.nih.gov/pubmed/34829916
http://dx.doi.org/10.3390/biomedicines9111687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616011/
https://www.ncbi.nlm.nih.gov/pubmed/34829916
http://dx.doi.org/10.3390/biomedicines9111687

Ejemplares similares